Related Experiment Video
Updated: Sep 28, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
[Gemcitabine-based combinations in inoperable pancreatic cancers]
Christophe Louvet1, Thierry André, Pascal Artru
1Service d'oncologie, médecine interne, Hôpital Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, 75012 Paris. christophe.louvet@sat.ap-hop-paris.fr
Abstract:
Gemcitabine administered as a weekly 1,000 mg/m2 30 minutes infusion is considered as the standard treatment of non resectable pancreatic adenocarcinoma. However, the limited results obtained with this standard therapy justify gemcitabine-based combinations studies. We summarize the results of studies combining gemcitabine with 5FU, docetaxel, platinum-compounds, irinotecan and epirubicin. Some combinations seem to achieve an interesting efficacy, and are now compared to gemcitabine alone.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
